Observed Signal · Oct 7, 2026 · Funding · Source: techcrunch · Impact: 3/5 · Sentiment: Positive
Healthleap Raises $38M for AI-Powered Hospital Patient Screening
Healthleap, a startup using AI to analyze patient records, has raised $38 million in seed and Series A funding. The round includes an $8 million seed co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures. The platform, deployed in over 50 hospitals, screens patients for conditions like malnutrition and delirium by extracting clinical concepts from clinician notes. Customers include Penn Medicine, Cedars-Sinai, and others. Revenue has grown over 10x in the past year. Funding will support expansion into more health conditions and outpatient care.
Significant funding for an AI-driven healthtech platform that applies machine learning to improve patient outcomes, indicating growing investment in AI applications in healthcare.
Track Sequoia Capital Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Healthleap raised $38 million in seed and Series A funding, including $8 million seed co-led by Sequoia Capital and First Round Capital and $30 million Series A led by Hummingbird Ventures.
- The AI platform is deployed in more than 50 hospitals, screening patients for malnutrition, delirium, and other conditions.
- Customers include Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare.
- Healthleap generated $23.8 million in annualized financial impact for the Hospital of the University of Pennsylvania through its malnutrition program.
- Revenue grew more than 10x over the past year.
Connected Companies & Entities
3 Entities mapped“The financing includes an $8 million seed round co-led by Sequoia Capital and First Round Capital....”
“The financing includes an $8 million seed round co-led by Sequoia Capital and First Round Capital....”
“The financing includes a $30 million Series A led by Hummingbird Ventures....”
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Health Force Raises €4.2M for Hospital AI Agents
Barcelona-based Health Force, a HealthTech startup, raised €4.2 million in Seed funding to expand its enterprise-grade AI agents for hospital operations. The round was led by LUMO Labs with participation from Step Venture, Next Tier Ventures, Target Global, and Calm/Storm. Founded in 2022 in Vienna, Health Force automates administrative tasks in hospitals, such as prior-authorisation checks, claims processing, and regulatory reporting. The company reports that its AI agents handle 75% of cases autonomously and are deployed at leading Italian hospital groups, including Humanitas and Gruppo San Donato, processing over 200,000 patient cases annually. The company plans to use the funds to expand into new workflows and European markets including Germany, France, and Spain.
Health AI Startup Heidi Raises $340M at $900M Valuation
Australian health AI startup Heidi has closed a Series C round of $100 million, led by Blackbird, with participation from Phoenix Court, Point72 Private Investments, and Headline, valuing the company at $900 million. In parallel, Heidi secured $240 million in growth financing from General Catalyst's Customer Value Fund, a revenue-based instrument that covers sales and customer acquisition costs. Combined, these deals provide $340 million in fresh capital. The company has raised $436.6 million to date. Heidi, founded in Melbourne, started as an AI scribe for clinical documentation and now positions itself as an 'AI care partner'. It reports 2.8 million patient encounters per week across 190 countries. The funding will support regulatory work for advanced clinical features in Europe and the UK, and expansion in the DACH region.
Biolevate raises €30M Series A for life sciences AI
Biolevate, a Paris-based life sciences AI company, has raised €30 million in Series A funding to scale its enterprise agentic AI platform designed to automate scientific and regulatory workflows. The round was co-led by RAISE France and Orange Ventures, with participation from MSD Global Health Innovation Fund, Station F, and existing investor EQT Ventures. The platform enables life sciences organizations to run thousands of concurrent AI agents, with outputs grounded in source evidence and human oversight, facilitating use in regulated environments. Since its 2024 seed round, Biolevate has expanded to over a dozen enterprise customers, achieving significant efficiency gains in literature reviews and regulatory intelligence. The company is opening a US office in Boston, has doubled headcount, and plans to double again, while also filing patents in Europe.
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.